These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 6283186)
1. Newer pertussis vaccines on horizon. González ER JAMA; 1982 Jul; 248(1):22-3. PubMed ID: 6283186 [No Abstract] [Full Text] [Related]
2. International symposium on pertussis evaluation and research on acellular pertussis vaccines. National Institute of Health in Tokyo and International Association of Biological Standardization. 14-15 September 1990 at Shizuoka, Japan. Biologicals; 1991 Apr; 19(2):145-9. PubMed ID: 1888495 [No Abstract] [Full Text] [Related]
3. Bordetella pertussis serotypes in Canada. Toma S; Lo H; Magus M Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182 [TBL] [Abstract][Full Text] [Related]
5. WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines. Arciniega JL; Corbel M; Dellepiane N; Dobbelaer R; Griffiths E; Heron I; Ivanoff B; Kreeftenberg H; Mastrantonio P; Meade B; Milstein J; Robertson S; Robinson A; Sato H; Sato Y; Schwanig M; Tiru M Biologicals; 1998 Sep; 26(3):195-204. PubMed ID: 10208721 [No Abstract] [Full Text] [Related]
7. Development of acellular pertussis vaccine in Japan. Oda M; Higurashi M Acta Paediatr Jpn; 1988 Apr; 30(2):136-42. PubMed ID: 2907709 [No Abstract] [Full Text] [Related]
8. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. Stevenson A; Roberts M FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):121-8. PubMed ID: 12832115 [TBL] [Abstract][Full Text] [Related]
9. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model. Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393 [TBL] [Abstract][Full Text] [Related]
10. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393 [TBL] [Abstract][Full Text] [Related]
11. [Acellular pertussis vaccine]. Wiedermann G; Ambrosch F; Vanura H Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820 [TBL] [Abstract][Full Text] [Related]
12. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3. Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898 [TBL] [Abstract][Full Text] [Related]
19. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis. Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261 [TBL] [Abstract][Full Text] [Related]
20. Bordetella pertussis iron regulated proteins as potential vaccine components. Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]